Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Waddington, John L.
1989.
Vol. 31,
Issue. ,
p.
297.
Waddington, John L.
Youssef, Hanafy A.
and
Kinsella, Anthony
1990.
Cognitive dysfunction in schizophrenia followed up over 5 years, and its longitudinal relationship to the emergence of tardive dyskinesia.
Psychological Medicine,
Vol. 20,
Issue. 4,
p.
835.
O'Callaghan, Eadbhard
Larkin, Conall
Kinsella, Anthony
and
Waddington, John L.
1990.
Obstetric Complications, the Putative Familial-Sporadic Distinction, and Tardive Dyskinesia in Schizophrenia.
British Journal of Psychiatry,
Vol. 157,
Issue. 4,
p.
578.
Tamminga, C. A.
Dale, J. M.
Goodman, L.
Kaneda, H.
and
Kaneda, N.
1990.
Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains.
Psychopharmacology,
Vol. 102,
Issue. 4,
p.
474.
Capellà, Dolors
and
Laporte, Joan-Ramon
1990.
Vol. 14,
Issue. ,
p.
45.
Tu, Jun‐Bi
1994.
Theory and practice of psychopharmacogenetics.
American Journal of Medical Genetics,
Vol. 54,
Issue. 4,
p.
391.
Raja, Michele
1995.
Tardive Dystonia.
European Archives of Psychiatry and Clinical Neuroscience,
Vol. 245,
Issue. 3,
p.
145.
Waddington, J. L.
and
Youssef, H. A.
1996.
Familial‐genetic and reproductive epidemiology of schizophrenia in rural Ireland: age at onset, familial morbid risk and parental fertility.
Acta Psychiatrica Scandinavica,
Vol. 93,
Issue. 1,
p.
62.
Basile, V S
Özdemir, V
Masellis, M
Walker, M L
Meltzer, H Y
Lieberman, J A
Potkin, S G
Alva, G
Kalow, W
Macciardi, F M
and
Kennedy, J L
2000.
A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia.
Molecular Psychiatry,
Vol. 5,
Issue. 4,
p.
410.
Basile, V S
Ozdemir, V
Masellis, M
Meltzer, H Y
Lieberman, J A
Potkin, S G
Macciardi, F M
Petronis, A
and
Kennedy, J L
2001.
Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia.
Molecular Psychiatry,
Vol. 6,
Issue. 2,
p.
230.
Schulze, Thomas G.
Schumacher, Johannes
Müller, Daniel J.
Krauss, Harald
Alfter, Daniela
Maroldt, Alexandra
Ahle, Guido
Maroldt, Ansgar‐Otto
Novo y Fernández, Ana
Weber, Thomas
Held, Tilo
Propping, Peter
Maier, Wolfgang
Nöthen, Markus M.
and
Rietschel, Marcella
2001.
Lack of association between a functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene and tardive dyskinesia in schizophrenia.
American Journal of Medical Genetics,
Vol. 105,
Issue. 6,
p.
498.
Tan, Ene-Choo
Chong, Siow-Ann
Mahendran, Rathi
Dong, Fang
and
Tan, Chay-Hoon
2001.
Susceptibility to neuroleptic-induced tardive dyskinesia and the T102C polymorphism in the serotonin type 2A receptor.
Biological Psychiatry,
Vol. 50,
Issue. 2,
p.
144.
Müller, D. J.
Schulze, T. G.
Knapp, M.
Held, T.
Krauss, H.
Weber, T.
Ahle, G.
Maroldt, A.
Alfter, D.
Maier, W.
Nöthen, M. M.
and
Rietschel, M.
2001.
Familial occurrence of tardive dyskinesia.
Acta Psychiatrica Scandinavica,
Vol. 104,
Issue. 5,
p.
375.
Müller, D. J.
Schulze, T. G.
Knapp, M.
Held, T.
Krauss, H.
Weber, T.
Ahle, G.
Maroldt, A.
Alfter, D.
Maier, W.
Nöthen, M. M.
and
Rietschel, M.
2001.
Familial occurrence of tardive dyskinesia.
Acta Psychiatrica Scandinavica,
Vol. 104,
Issue. 5,
p.
375.
Tan, Ene-Choo
Chong, Siow-Ann
Mahendran, Rathi
Tan, Chay Hoon
and
Teo, Yik-Ying
2003.
Mu opioid receptor gene polymorphism and neuroleptic-induced tardive dyskinesia in patients with schizophrenia.
Schizophrenia Research,
Vol. 65,
Issue. 1,
p.
61.
Chong, Siow‐Ann
Tan, Ene‐Choo
Tan, Chay Hoon
Mythily
and
Chan, Yiong Huak
2003.
Polymorphisms of dopamine receptors and tardive dyskinesia among Chinese patients with schizophrenia.
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics,
Vol. 116B,
Issue. 1,
p.
51.
Herken, Hasan
Erdal, M. Emin
Böke, Ömer
and
Savaş, Haluk A.
2003.
Tardive dyskinesia is not associated with the polymorphisms of 5-HT2A receptor gene, serotonin transporter gene and catechol-o-methyltransferase gene ⋆.
European Psychiatry,
Vol. 18,
Issue. 2,
p.
77.
Werge, T
Elbæk, Z
Andersen, M B
Lundbæk, J A
and
Rasmussen, H B
2003.
Cebus apella, a nonhuman primate highly susceptible to neuroleptic side effects, carries the GLY9 dopamine receptor D3 associated with tardive dyskinesia in humans.
The Pharmacogenomics Journal,
Vol. 3,
Issue. 2,
p.
97.
Lowrimore, Patricia
Mulvihill, David
Epstein, Andrew
McCormack, Michael
and
Wang, Yuh‐Hwa
2004.
CAG nucleotide repeat profiles in persons with schizophrenia or schizoaffective disorders with and without tardive dyskinesia: Pilot study.
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics,
Vol. 128B,
Issue. 1,
p.
15.
Arranz, M J
and
de Leon, J
2007.
Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
Molecular Psychiatry,
Vol. 12,
Issue. 8,
p.
707.
eLetters
No eLetters have been published for this article.